Research
Hormonal
Abdominal obesity, dysglycemia, and higher income are independent risk factors for NAFL in nonobese populations, suggesting that metabolic dysfunction (insulin resistance) drives liver fat deposition more than general adiposity.
Monitor your waist circumference and blood sugar levels, not just your weight. In populations with lower average body weights, metabolic health markers like fasting glucose and waist size are better predictors of liver health than BMI alone.
GoodSupportsHIGH confidence
Abdominal obesity, dysglycemia (fasting plasma glucose >100 mg/dL or elevated homeostatic model assessment of insulin resistance), and higher income were the other risk factors.
Why this rating
Multivariate analysis adjusts for confounders, and the sample size is robust for an epidemiological study.
Source
Nonobese Population in A Developing Country Has A High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease
Kausik Das et al. · Hepatology · 2010
DOI 10.1002/hep.23567
cohort · n=1911Cited 466×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →